Pseudoporphyria is a photo-induced blistering disorder with increased skin fragility, caused among others by nonsteroidal antiinflammatory drugs. Lesions heal with scarring and milia. Porphyrin screen studies are normal in this disease. Histology and immunofluorescence resembles porphyria cutanea tarda. In this report we describe a cluster of three cases of naproxen-induced pseudoporphyria, and review briefly previously reported cases induced by naproxen. The majority of reported cases involve children. Physicans should be aware of this reversible skin disorder.
Pseudoporphyria is a blistering disorder with increased skin fragility. It resembles porphyria cutanea taiJda (PCT) in its5 reaction to the intake of certain drugs and sunlight exposure, but without disorders in the porphy rin metabolism. Only sunlight exposed areas of the skin are involved; face, dorsal surfaces of hands and feet and less often the neck except the area underneath the chin and behind the ears. Usually blisters heal with scarring and milia. Blisters are subepidermal and his-» tology is identical to abnormalities found in PCT. PCT patients lack uroporphyrinogen decarboxylase, an en zyme of the heme biosynthesis, by contrast in pseudoporphyria porphyrin screen in erythrocytes, urine and feces is normal. Pseudoporphyria due to naproxen was believed to be a rare adverse reaction to the drug, although by now a hundred cases have been reported.
We report here three cases o f pseudoporphyria due to naproxen and review briefly the literature, the estab lishment of diagnosis and hypothetical mechanisms. A 58-year-old white man, who had used sunbeds regu larly for several years, had a 6-week history of blister ing and skin fragility of the dorsa o f both hands. His medical history comprised a longstanding, moderately active, ankylosing spondylitis, for which he took NSAIDs for many years, and prostatism, without hepa titis, porphyria or photosensitivity disorders. The pa-4 tient reported that he had experienced the same lesions about 5 to 6 years earlier, but to a lesser extent and degree. On both occasions he was using naproxen 500 mg b.i.d. Examination of the skin showed small blisters and some old lesions with slight scarring. No other abnormalities of the skin were seen. Liverfunction tests, porphyrin screen in erythrocytes and urine re vealed normal. Skin biopsies were not conclusive be-cause of a sampling error. He decided to continue naproxen because of good efficacy, despite advise to stop, and started to use a sunfilter when using sunbeds. Skin lesions healed with scarring within a few weeks. Almost 1.5 years later, no new skin lesions occurred despite naproxen use, but slight skin fragility re mained. A total of 100 cases of pseudoporphyria due to naproxen are known, remarkably 74 of these were children. The mean age of children was 7 years (range 1-18 years) and in adults age ranged from 21 to 84 years. In adults it appeared that mostly women were involved (14 women versus 7 men, 5 not reported), in most cases involving children sex was not reported. Most cases manifested itself during summer, not al ways clearly related to sunlight exposure, 3 cases oc curred after visiting a solarium. Dose of naproxen in adults was 250 to 1500 mg/day, in children the mean dose was 13 mg/kg/day, and the use of naproxen ranged from a few weeks to several years before onset of pseudoporphyria. Most frequently lesions occurred on the dorsal surfaces of hands and feet, in some cases in the face, in a few cases on the neck and in one case also on both knees. Scarring usually remained after healing but showed a tendency to fade. Porphyrin screening was done in the majority of cases and re vealed normal, Histology was reported in 16 cases and in 11 of these 19 biopsies, immunofluorescence was done, all biopsies were conclusive for PCT-like ab normalities. Naproxen was stopped in all patients after which skin lesions healed. In 14 cases the time needed 186 for healing was described and was on average 5 weeks (range 1 week to 2 months).
All three cases described here manifested itself in the summer of 1992, which was an ordinary Dutch summer, though one case manifested itself at the Canary Islands. Pseudoporphyria due to naproxen was not seen earlier at our clinics. Our two adults took part in a 48-week double-blind study comparing ß-cyclodextrin-piroxicam (n = 30) with naproxen (n = 29) in ankylosing spondylitis. One of our-cases (case 2) dif fers from other cases in the literature as skin lesions healed while naproxen was still being administered, but patient had started to use a sunfilter. One case of pseudoporphyria due to nalidix acid behaved similarly (10) . No porphyrin screen was done in case 3, but the causal relation with discontinuation of naproxen and subsiding of characteristic skin lesions confirm the diagnosis.
Although phototoxicity is widely accepted, several hypotheses have been developed. Naproxen is known to stabilize the liposomal membrane in vitro and to be a potent inhibitor of cyclo-oxygenase. In most hypothe ses sunlight plays a central role. The inflammation of the sun exposed skin may be due to: a. the chemical structure of NSAIDs itself which may induce photosensitation of the skin (4, 11) ; b. the release of free oxygen radicals by naproxen which may contribute to the phototoxic reaction (4, 8), probably as well aggra vated by complement compounds (7). Other hypoth eses suggest that pseudoporphyria patients have minor disturbances of heme-biosynthesis leading to symp toms in case of excessive sunlight exposure (5, 12), perhaps sometimes associated with intake of alcohol (5), estrogens (5) or eventually minor skin trauma (6). The relation with sunlight exposure is confirmed espe cially in three patients with vitiligo in whom bullae were only present on areas of vitiligo (12) (13) (14) . Not only exposure to a high intensity of sunlight may induce pseudoporphyria, but also multiple prolonged low-grade exposure may cause skin lesion resulting mostly in decreased adhesion of dermis and epidermis (9, 15).
It is not easy to explain the larger frequency of pseudoporphyria due to naproxen in children (Allen et al. (6) even reported that 6% of ail children using naproxen experienced pseudoporphyria), especially as far less children than adults use naproxen. Possibly children experience more frequently trauma of the skin during sunlight exposure and are more exposed.
Pseudopoiphyria might be seen as a 'diagnosis per exclusionen*. PCT, epidermolysis bullosa acquisita and hydroa vacciniforme must first be ruled out as a diag nosis. The-only difference between PCT and pseudo porphyria is the negative porphyrin screen in the latter.
It may be concluded that the pathogenesis of pseu dopoiphyria due to naproxen is still not clear, but there seems to be a relation to sunlight exposure and perhaps minor skin trauma. Discontinuation of naproxen is the best treatment. One should be aware of this adverse drug reaction, especially in fair skinned patients and even more in children.
